Last updated on March 2018

Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Mite Allergy

Brief description of study

The purpose of the study is to evaluate the more efficient dose for the treatment of rhinitis/rhinoconjunctivitis against mite allergy

Detailed Study Description

Double blind placebo-controlled study. The subjects will receive medication during 4 months.

Clinical Study Identifier: NCT02661854

Contact Investigators or Research Sites near you

Start Over

Luis Angel Navarro Seisdedos

Hospital Lluis Alcanyis de X tiva
Xátiva, Spain
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.